FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 176 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 10.41 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,144,000 | +2002.0% | 56,930 | +849.1% | 0.00% | – |
| Q4 2020 | $102,000 | +436.8% | 5,998 | +41.8% | 0.00% | – |
| Q3 2020 | $19,000 | -94.7% | 4,230 | -92.8% | 0.00% | – |
| Q2 2020 | $357,000 | +643.8% | 58,547 | +178.6% | 0.00% | – |
| Q1 2020 | $48,000 | -79.5% | 21,016 | -58.8% | 0.00% | – |
| Q4 2019 | $234,000 | -49.4% | 51,006 | -57.2% | 0.00% | – |
| Q3 2019 | $462,000 | +3750.0% | 119,213 | +5636.9% | 0.00% | – |
| Q2 2019 | $12,000 | -69.2% | 2,078 | -27.2% | 0.00% | – |
| Q1 2019 | $39,000 | -95.8% | 2,854 | -97.1% | 0.00% | – |
| Q4 2018 | $925,000 | +683.9% | 99,438 | +1072.1% | 0.00% | – |
| Q3 2018 | $118,000 | +13.5% | 8,484 | +29.4% | 0.00% | – |
| Q2 2018 | $104,000 | -93.9% | 6,557 | -93.4% | 0.00% | -100.0% |
| Q1 2018 | $1,695,000 | +583.5% | 98,653 | +773.8% | 0.00% | – |
| Q4 2017 | $248,000 | -15.4% | 11,290 | +57.6% | 0.00% | – |
| Q3 2017 | $293,000 | +26.8% | 7,164 | -6.7% | 0.00% | – |
| Q2 2017 | $231,000 | +5.0% | 7,676 | +26.4% | 0.00% | – |
| Q1 2017 | $220,000 | -80.1% | 6,072 | -72.5% | 0.00% | -100.0% |
| Q4 2016 | $1,105,000 | +41.3% | 22,058 | +48.2% | 0.00% | – |
| Q3 2016 | $782,000 | +942.7% | 14,888 | +726.2% | 0.00% | – |
| Q2 2016 | $75,000 | +127.3% | 1,802 | +121.1% | 0.00% | – |
| Q1 2016 | $33,000 | -10.8% | 815 | -7.0% | 0.00% | – |
| Q4 2015 | $37,000 | +68.2% | 876 | -2.4% | 0.00% | – |
| Q2 2015 | $22,000 | – | 898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|